Pds Biotech Completes $35 Million Financing Agreement Led By Horizon Technology Finance
Amount Raised
$35 Million
Round Type
Debt Financing
PrincetonBiotechnologyHealth CareTherapeuticsDescription
PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of molecularly targeted cancer immunotherapies and infectious disease vaccines based on the Company’s proprietary Versamune® and InfectimuneTM T cell activating technologies, today announced that it has entered into a debt financing agreement led by Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) to provide up to a $35.0 million term loan.
Quick answer
PDS Biotech raised $35 Million in a Debt Financing round, dated August 24, 2022. PDS Biotech is based in Princeton, New Jersey, United States.
- How much did PDS Biotech raise?
- PDS Biotech raised $35 Million in a Debt Financing round on August 24, 2022.
- What does PDS Biotech do?
- PDS Biotech is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies based on the Versamune® platform, a T-cell activating technology, designed to harness the power of..
- Where is PDS Biotech based and how big is it?
- PDS Biotech is based in Princeton, New Jersey, United States. Fundz records about 21 employees.
- Who are the decision-makers at PDS Biotech?
- Fundz holds 2 contacts at PDS Biotech, including the Vice President, Technical Operations & Manufacturing. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as PDS Biotech that raised within 45 days of this round, from Fundz verified event records.
- RadioMedix raised $40M (Series A) on October 7, 2022.
- NewcelX raised $4M (Seed) on October 7, 2022.
- Valitor raised an undisclosed amount (Series B) on October 5, 2022.
- Vergent Bioscience raised $22M (Series B) on October 4, 2022.
- Cellarity raised $121M (Series C) on October 4, 2022.
- Gamida Cell raised $25M (Funding Round) on September 28, 2022.
Who to call at PDS Biotech, and when
A new round usually means PDS Biotech is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PDS Biotech raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PDS Biotech, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PDS Biotech. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PDS Biotech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
PDS Biotech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.